Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1

被引：50
作者：
Fesler, Andrew [1 ]
Liu, Hua [1 ]
Ju, Jingfang [1 ]
机构：
[1] SUNY Stony Brook, Sch Med, Dept Pathol, Stony Brook, NY 11794 USA
来源：
ONCOTARGET | 2018年 / 9卷 / 02期
关键词：
5-fluorouracil; miR-15a; colorectal cancer; chemoresistance; modified miRNA; STEM-CELLS; MESENCHYMAL TRANSITION; MEDIATED SUPPRESSION; DOWN-REGULATION; SELF-RENEWAL; C-MYC; COLON; 5-FLUOROURACIL; PROLIFERATION; METASTASIS;
D O I：
10.18632/oncotarget.23414
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite advances in colon cancer treatments, resistance and recurrence remain a significant challenge in treating patients. Novel therapeutic strategies are in urgent need to overcome resistance and improve patient outcomes. MicroRNA based therapeutics have potential to help combat resistance. In this study, we have shown that low miR-15a expression correlates with poor patient prognosis. We have demonstrated the therapeutic potential of miR-15a in colon cancer. miR-15a inhibits several important genes (BCL2, BMI1, YAP1 and DCLK1), decreasing cancer progression and resistance. Additionally, by replacing uracil in miR-15a with 5-fluorouracil, we created a novel miR-15a mimic with enhanced therapeutic potential. This mimic maintains target specificity and is more potent than unmodified miR-15a in vitro and inhibits colon tumor metastasis in vivo. This mimic has great potential for therapeutic development for treating colon cancer patients. This novel modification has potential to advance the development of other microRNA based therapeutics beyond miR-15a.
引用
收藏
页码：2367 / 2383
页数：17
相关论文
共 58 条
[1]   YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells [J].
Bora-Singhal, Namrata ;
Nguyen, Jonathan ;
Schaal, Courtney ;
Perumal, Deepak ;
Singh, Sandeep ;
Coppola, Domenico ;
Chellappan, Srikumar .
STEM CELLS, 2015, 33 (06) :1705-1718
[2]   Colon cancer stem cells - From basic to clinical application [J].
Botchkina, Galina .
CANCER LETTERS, 2013, 338 (01) :127-140
[3]  
Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19
[4]   Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529
[5]   YAP1 increases organ size and expands undifferentiated progenitor cells [J].
Camargo, Fernando D. ;
Gokhale, Sumita ;
Johnnidis, Jonathan B. ;
Fu, Dongdong ;
Bell, George W. ;
Jaenisch, Rudolf ;
Brummelkamp, Thijn R. .
CURRENT BIOLOGY, 2007, 17 (23) :2054-2060
[6]   THE CATALYTIC MECHANISM AND STRUCTURE OF THYMIDYLATE SYNTHASE [J].
CARRERAS, CW ;
SANTI, DV .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :721-762
[7]   Characterization of sphere-forming HCT116 clones by whole RNA sequencing [J].
Chung, Eunkyung ;
Oh, Inkyung ;
Lee, Kil Yeon .
ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2016, 90 (04) :183-193
[8]   miR-15 and miR-16 induce apoptosis by targeting BCL2 [J].
Cimmino, A ;
Calin, GA ;
Fabbri, M ;
Iorio, MV ;
Ferracin, M ;
Shimizu, M ;
Wojcik, SE ;
Aqeilan, RI ;
Zupo, S ;
Dono, M ;
Rassenti, L ;
Alder, H ;
Volinia, S ;
Liu, CG ;
Kipps, TJ ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (39) :13944-13949
[9]   Recent Therapeutic Advances in the Treatment of Colorectal Cancer [J].
Ciombor, Kristen K. ;
Wu, Christina ;
Goldberg, Richard M. .
ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 :83-95
[10]   The BCL2 family: Regulators of the cellular life-or-death switch [J].
Cory, S ;
Adams, JM .
NATURE REVIEWS CANCER, 2002, 2 (09) :647-656
123456